HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?

J Epidemiol Glob Health. 2017 Mar;7(1):11-19. doi: 10.1016/j.jegh.2015.12.002. Epub 2016 Jan 25.

Abstract

For certain subgroups within people living with the human immunodeficiency virus (HIV) [active tuberculosis (TB), pregnant women, children <5years old, and serodiscordant couples], the World Health Organization recommends antiretroviral therapy (ART) irrespective of CD4 count. Another subgroup which has received increased attention is "HIV-infected presumptive TB patients without TB". In this study, we assess the proportion of HIV-infected presumptive TB patients eligible for ART in Karnataka State (population 60million), India. This was a cross-sectional analysis of data of HIV-infected presumptive TB patients diagnosed in May 2015 abstracted from national TB and HIV program records. Of 42,585 presumptive TB patients, 28,964 (68%) were tested for HIV and 2262 (8%) were HIV positive. Of the latter, 377 (17%) had active TB. Of 1885 "presumptive TB patients without active TB", 1100 (58%) were already receiving ART. Of the remaining 785 who were not receiving ART, 617 (79%) were assessed for ART eligibility and of those, 548 (89%) were eligible for ART. About 90% of "HIV-infected presumptive TB patients without TB" were eligible for ART. This evidence supports a public health approach of starting all "HIV-infected presumptive TB patients without TB" on ART irrespective of CD4 count in line with global thinking about 'test and treat'.

Keywords: ART eligibility; ART initiation criteria; HIV-infected TB suspects; HIV-infected presumptive TB patients; Operational research; WHO 2013 ART guidelines.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use*
  • Comorbidity
  • Cough / epidemiology*
  • Cross-Sectional Studies
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology*
  • Health Services Accessibility / statistics & numerical data*
  • Humans
  • India / epidemiology
  • Male
  • Middle Aged
  • Tuberculosis*

Substances

  • Anti-Retroviral Agents